Biosimilars Market Analysis to 2025 with Biocon, Samsung BioLogics, Mylan, Amgen, Celltrion, Healthcare, Sandoz International, Teva Pharmaceutical Industries, Pfizer, STADA Arzneimittel, Dr. Reddy’s Laboratories

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global biosimilars based on product and application. It also provides market size and forecast till 2025 for overall biosimilars market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East &Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

The key players influencing the market are Teva Pharmaceutical Industries Ltd., Pfizer Inc., Biocon, Samsung BioLogics, Mylan N.V., Amgen Inc., Celltrion, Healthcare Co.,Ltd., Sandoz International GmbH, STADA Arzneimittel AG, Dr. Reddy’s Laboratories Ltd. and others.

The growth of the global biosimilars market can be attributed to the growing demand of pharmaceutical drug supplements, especially for the high priced patented drugs expected to upsurge the growth of the market. Additionally, increasing incidences of chronic diseases add novel opportunities for the global biosimilars market over the forecast period.

Get sample copy: http://bit.ly/2TJLfBZ

On the basis of product the market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, peptides and others. The recombinant non-glycosylated proteins market is further segmented into insulin, recombinant human growth hormone, granulocyte colony-stimulating factor and interferons. The recombinant glycosylated proteins segment is bifurcated into monoclonal antibodies and erythropoietin. The peptides segment is also classified into calcitonin and glucagon. Based on application the market is segmented into oncology, autoimmune diseases, chronic diseases, blood disorders, infectious diseases, growth hormone deficiency and others.

A biosimilar is a biological product which is similar to an FDA approved biologic product of another manufacturer. Owing to the complexities associated with development & manufacture of biosimilar products, these are manufactured by companies with highly skillful workforce and deep scientific expertise. The FDA approval process for biosimilar products is rigorous and enables high safety to the end users.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Buy this report: http://bit.ly/2TIt4wP

TABLE OF CONTENTS

1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance

2 Key Takeaways

3 Biosimilars Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Biosimilars Market – By Product
3.2.2 Biosimilars Market – By Application
3.2.3 Biosimilars Market – By Region
3.2.3.1 By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe – PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East and Africa – PEST Analysis
3.3.5 South and Central America – PEST Analysis

4 Biosimilars Market – Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 Biosimilars Market - Global Analysis
5.1 Global Biosimilars Market Overview
5.2 Global Biosimilars Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trial Analysis
5.6 Expert Opinions

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.